Bcl-XL: A multifunctional anti-apoptotic protein

Kerr, 1972, Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics, Br. J. Cancer, 26, 239, 10.1038/bjc.1972.33 Silvestris, 1995, Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms, Ann. Ital. Med. Int., 10, 7 Hetts, 1998, To die or not to die: an overview of apoptosis and its role in disease, JAMA., 279, 300, 10.1001/jama.279.4.300 Tsujimoto, 1985, Involvement of the Bcl-2 gene in human follicular lymphoma, Science., 228, 1440, 10.1126/science.3874430 Tsujimoto, 1984, Cloning of the chromosome breakpoint of neoplastic B cells with the t (14;18) chromosome translocation, Science., 226, 1097, 10.1126/science.6093263 Tsujimoto, 1985, Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t (11;14) chromosome translocation, Nature., 315, 340, 10.1038/315340a0 Cleary, 1985, Nucleotide sequence of a t (14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18, Proc. Natl. Acad. Sci. U.S.A., 82, 7439, 10.1073/pnas.82.21.7439 Jagani, 2016, Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: a mini review, Artif. Cells Nanomed. Biotechnol., 44, 1212, 10.3109/21691401.2015.1019668 Boise, 1993, Bcl-X, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, 74, 597, 10.1016/0092-8674(93)90508-N Warren, 2019, Bcl-2 family isoforms in apoptosis and cancer, Cell Death Dis., 10, 177, 10.1038/s41419-019-1407-6 Muchmore, 1996, X-ray and NMR structure of human Bcl-XL, an inhibitor of programmed cell death, Nature, 381, 335, 10.1038/381335a0 Aritomi, 1997, Crystal structure of rat Bcl-XL: implications for the function of the Bcl-2 protein family, J. Biol. Chem., 272, 27886, 10.1074/jbc.272.44.27886 Liu, 2003, The structure of a Bcl-XL/Bim fragment complex: implications for Bim function, Immunity, 19, 341, 10.1016/S1074-7613(03)00234-6 Lewis, 2014, Bcl-2 family in inter-organelle modulation of calcium signaling; roles in bioenergetics and cell survival, J. Bioenerg. Biomembr., 46, 1, 10.1007/s10863-013-9527-7 Lee, 2019, The structural biology of Bcl-X, Int. J. Mol. Sci., 20, 2234, 10.3390/ijms20092234 Maity, 2018, Flexibility enables to discriminate between ligands: lessons from structural ensembles of Bcl-XL and Mcl-1, Comput. Biol. Chem., 77, 17, 10.1016/j.compbiolchem.2018.08.007 Gabellini, 2017, Non-canonical roles of Bcl-2 and Bcl-XL proteins: relevance of BH4 domain, Carcinogenesis, 38, 579, 10.1093/carcin/bgx016 Jin, 2005, Overview of cell death signaling pathways, Cancer Biol. Ther., 4, 139, 10.4161/cbt.4.2.1508 de Jong, 2018, Bcl-XL as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma, Oncogenesis, 7, 74, 10.1038/s41389-018-0084-0 Liu, 2014, Effect of Bcl-XL gene expression silenced by RNA interference on invasion of human colorectal cancer cells, J. BUON, 19, 925 Scherr, 2016, Bcl-XL is an oncogenic driver in colorectal cancer, Cell Death Dis., 7, E2342, 10.1038/cddis.2016.233 Shimizu, 2010, The let-7 family of microRNAs inhibits Bcl-XL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma, J. Hepatol., 52, 698, 10.1016/j.jhep.2009.12.024 Hernandez, 2013, Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-XL, Leuk. Lymphoma, 54, 1048, 10.3109/10428194.2012.733874 Chen, 2012, Increase of the therapeutic effect on non-small-cell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-XL in vitro, Exp. Ther. Med., 3, 255, 10.3892/etm.2011.381 Lee, 2014, Knockdown of Bcl-XL enhances growth-inhibiting and apoptosis-inducing effects of resveratrol and clofarabine in malignant mesothelioma H-2452 cells, J. Korean Med. Sci., 29, 1464, 10.3346/jkms.2014.29.11.1464 Lee, 2019, Bcl-XL and Mcl-1 are the key Bcl-2 family proteins in melanoma cell survival, Cell Death Dis., 10, 342, 10.1038/s41419-019-1568-3 Brotin, 2010, Bcl-XL and Mcl-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis, Int. J. Cancer, 126, 885 Varin, 2010, Downregulation of Bcl-XL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy, Carcinogenesis, 31, 984, 10.1093/carcin/bgq026 Duan, 2018, Co-delivery of Aurora-A inhibitor XY-4 and Bcl-XL siRNA enhances antitumor efficacy for melanoma therapy, Int. J. Nanomed. Nanosurg., 13, 1443, 10.2147/IJN.S147759 Melkko, 2010, Isolation of a small-molecule inhibitor of the antiapoptotic protein Bcl-XL from a DNA-encoded chemical library, ChemMedChem., 5, 584, 10.1002/cmdc.200900520 Takei, 2019, siRNA-based drug targeting human Bcl-XL against cancers, Methods Mol. Biol., 1974, 31, 10.1007/978-1-4939-9220-1_3 Ashkenazi, 2017, From basic apoptosis discoveries to advanced selective Bcl-2 family inhibitors, Nat. Rev. Drug Discov., 16, 273, 10.1038/nrd.2016.253 Park, 2008, Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins, J. Med. Chem., 51, 6902, 10.1021/jm800669s Kipps, 2010, Navitoclax (ABT-263) plus fludarabine/cyclophosphamide/rituximab (FCR) or bendamustine/rituximab (BR): a phase 1 study in patients with relapsed/refractory chronic lymphocytic leukemia (CLL), Blood, 118, 3904, 10.1182/blood.V118.21.3904.3904 Kipps, 2015, A phase 2 study of the BH3 mimetic Bcl-2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia, Leuk. Lymphoma, 56, 2826, 10.3109/10428194.2015.1030638 Mason, 2007, Programmed anuclear cell death delimits platelet life span, Cell, 128, 1173, 10.1016/j.cell.2007.01.037 Leslie, 2010, Beyond clotting: the powers of platelets, Science, 328, 562, 10.1126/science.328.5978.562 Davids, 2011, ABT-199: a new hope for selective Bcl-2 inhibition, Cancer Cell, 23, 139, 10.1016/j.ccr.2013.01.018 Wang, 2019, Bevacizumab synergises with the Bcl-2 inhibitor venetoclax to effectively treat B-cell non-Hodgkin’s lymphoma, Eur. J. Haematol., 103, 234, 10.1111/ejh.13279 Zhu, 2019, Co-operation of ABT-199 and gemcitabine in impeding DNA damage repair and inducing cell apoptosis for synergistic therapy of T-cell acute lymphoblastic leukemia, Anticancer Drugs, 30, 138, 10.1097/CAD.0000000000000702 Li, 2019, The Mcl-1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells, Leukemia, 33, 262, 10.1038/s41375-018-0201-2 Souers, 2013, ABT-199, a potent and selective Bcl-2 inhibitor, achieves antitumor activity while sparing platelets, Nat. Med., 19, 202, 10.1038/nm.3048 Vandenberg, 2013, ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia, Blood., 121, 2285, 10.1182/blood-2013-01-475855 Debrincat, 2015, Bcl-2 is dispensable for thrombopoiesis and platelet survival, Cell Death Dis., 6, E1721, 10.1038/cddis.2015.97 Tao, 2014, Discovery of a potent and selective Bcl-XL inhibitor with in vivo activity, ACS Med. Chem. Lett., 5, 1088, 10.1021/ml5001867 Liu, 2019, Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2, Elife, 8, E37689, 10.7554/eLife.37689 Baruah, 2016, Dynamic Bcl-XL (S49) and (S62) phosphorylation/dephosphorylation during mitosis prevents chromosome instability and aneuploidy in normal human diploid fibroblasts, PLoS One, 11, 10.1371/journal.pone.0159091 Wang, 2014, Phospho-Bcl-XL (Ser62) influences spindle assembly and chromosome segregation during mitosis, Cell Cycle, 13, 1313, 10.4161/cc.28293 Choi, 2016, Bcl-XL promotes metastasis independent of its anti-apoptotic activity, Nat. Commun., 7, 10384, 10.1038/ncomms10384 Byrd, 1999, Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells, Blood, 94, 1401, 10.1182/blood.V94.4.1401 Khan, 2004, Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma, Br. J. Haematol., 125, 156, 10.1111/j.1365-2141.2004.04882.x Delia, 1995, Regulation of apoptosis by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated Bcl-2, Blood, 85, 359, 10.1182/blood.V85.2.359.359 Wei, 2010, BI-97C1, an optically pure apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins, J. Med. Chem., 53, 4166, 10.1021/jm1001265 Arnold, 2008, Preclinical studies of apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in follicular small cleaved cell lymphoma model, Mol. Cancer, 7, 20, 10.1186/1476-4598-7-20 Bruncko, 2007, Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-XL, J. Med. Chem., 50, 641, 10.1021/jm061152t Tse, 2008, ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor, Cancer Res., 68, 3421, 10.1158/0008-5472.CAN-07-5836 Nguyen, 2007, Small molecule obatoclax (GX15-070) antagonizes Mcl-1 and overcomes Mcl-1-mediated resistance to apoptosis, Proc. Natl. Acad. Sci. U.S.A., 104, 19512, 10.1073/pnas.0709443104 Oliver, 2004, In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells, Clin. Cancer Res., 10, 7757, 10.1158/1078-0432.CCR-04-0551 Baggstrom, 2011, A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer, J. Thorac. Oncol., 6, 1757, 10.1097/JTO.0b013e31822e2941 Shoemaker, 2006, A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo, Cancer Res., 66, 8731, 10.1158/0008-5472.CAN-06-0367 Wang, 2006, Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins, J. Med. Chem., 49, 6139, 10.1021/jm060460o Doshi, 2006, Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer, J. Med. Chem., 49, 7731, 10.1021/jm060968r Tao, 2014, Discovery of a potent and selective Bcl-XL inhibitor with in vivo activity, ACS Med. Chem. Lett., 5, 1088, 10.1021/ml5001867 Zhu, 2017, New agents that target senescent cells: the flavone, fisetin, and the Bcl-X inhibitors, A1331852 and A1155463, Aging, 9, 955, 10.18632/aging.101202 Lessene, 2013, Structure-guided design of a selective Bcl-XL inhibitor, Nat. Chem. Biol., 9, 390, 10.1038/nchembio.1246 Teicher, 2000, Molecular targets and cancer therapeutics: discovery, development and clinical validation, Drug Resist. Updat., 3, 67, 10.1054/drup.2000.0123 Huang, 2000, Bcl-2 family proteins as targets for anticancer drug design, Oncogene, 19, 6627, 10.1038/sj.onc.1204087 Loriot, 2014, Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer, Cell Death Dis., 5, E1423, 10.1038/cddis.2014.365 Bai, 2014, BM-1197: a novel and specific Bcl-2/Bcl-XL inhibitor inducing complete and long-lasting tumor regression in vivo, PLoS One, 9, E99404, 10.1371/journal.pone.0099404 Aguilar, 2013, A potent and highly efficacious Bcl-2/Bcl-XL inhibitor, J. Med. Chem., 56, 3048, 10.1021/jm4001105 Gozuacik, 2004, Autophagy as a cell death and tumor suppressor mechanism, Oncogene, 23, 2891, 10.1038/sj.onc.1207521 Klionsky, 2000, Autophagy as a regulated pathway of cellular degradation, Science, 290, 1717, 10.1126/science.290.5497.1717 Anglade, 1997, Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease, Histol. Histopathol., 12, 25 New, 2019, Autophagy-dependent secretion: mechanism, factors secreted, and disease implications, Autophagy, 15, 1682, 10.1080/15548627.2019.1596479 Mathew, 2007, Role of autophagy in cancer, Nat. Rev. Cancer, 7, 961, 10.1038/nrc2254 Liang, 1999, Induction of autophagy and inhibition of tumorigenesis by Beclin 1, Nature, 402, 672, 10.1038/45257 Wirawan, 2010, Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria, Cell Death Dis., 1, E18, 10.1038/cddis.2009.16 Mergny, 2010, Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1, Oncogene, 29, 1717, 10.1038/onc.2009.519 Zhu, 2010, Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis, Protein Cell, 1, 468, 10.1007/s13238-010-0048-4 Pattingre, 2005, Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy, Cell, 122, 927, 10.1016/j.cell.2005.07.002 Zhou, 2011, Bcl-2 and Bcl-XL play important roles in the crosstalk between autophagy and apoptosis, FEBS J., 278, 403, 10.1111/j.1742-4658.2010.07965.x Maiuri, 2007, Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1, EMBO J., 26, 2527, 10.1038/sj.emboj.7601689 Pimkina, 2009, ARF induces autophagy by virtue of interaction with Bcl-XL, J. Biol. Chem., 284, 2803, 10.1074/jbc.M804705200 Zalckvar, 2009, DAP-kinase-mediated phosphorylation on the BH3 domain of Beclin 1 promotes dissociation of Beclin 1 from Bcl-XL and induction of autophagy, EMBO Rep., 10, 285, 10.1038/embor.2008.246 Matsuda, 2015, Hypercapnia inhibits autophagy and bacterial killing in human macrophages by increasing expression of Bcl-2 and Bcl-XL, J. Immunol., 194, 5388, 10.4049/jimmunol.1500150 Nakajima, 2017, Bcl-XL affects Group A Streptococcus-induced autophagy directly, by inhibiting fusion between autophagosomes and lysosomes, and indirectly, by inhibiting bacterial internalization via interaction with Beclin 1-UVRAG, PLoS One, 12, 10.1371/journal.pone.0170138 Jonas, 2006, Bcl-XL regulates synaptic plasticity, Mol. Interv., 6, 208, 10.1124/mi.6.4.7 Jonas, 2014, Bcl-XL in neuroprotection and plasticity, Front. Physiol., 5, 355, 10.3389/fphys.2014.00355 Park, 2014, Mitochondrial membrane protein Bcl-XL, a regulator of adult neuronal growth and synaptic plasticity: multiple functions beyond apoptosis, Neural Regen. Res., 9, 1706, 10.4103/1673-5374.143413 Park, 2015, Bcl-XL is necessary for neurite outgrowth in hippocampal neurons, Antioxid. Redox Signal., 22, 93, 10.1089/ars.2013.5570 Iyer, 2013, Developmental patterns of DR6 in normal human hippocampus and in down syndrome, J. Neurodev. Disord., 5, 10, 10.1186/1866-1955-5-10 Jonas, 2003, Modulation of synaptic transmission by the Bcl-2 family protein Bcl-XL, J. Neurosci., 23, 8423, 10.1523/JNEUROSCI.23-23-08423.2003 Li, 2008, Bcl-XL induces DRP1-dependent synapse formation in cultured hippocampal neurons, Proc. Natl. Acad. Sci. U.S.A., 105, 2169, 10.1073/pnas.0711647105 Li, 2013, A Bcl-XL-DRP1 complex regulates synaptic vesicle membrane dynamics during endocytosis, Nat. Cell Biol., 15, 773, 10.1038/ncb2791 Fogarty, 2018, Mcl-1 and Bcl-XL are essential for survival of the developing nervous system, Cell Death Differ., 26, 1501, 10.1038/s41418-018-0225-1 Song, 2018, Stem cells: a promising candidate to treat neurological disorders, Neural Regen. Res., 13, 1294, 10.4103/1673-5374.235085 Pang, 2017, Neural stem cell transplantation is associated with inhibition of apoptosis, Bcl-XL upregulation, and recovery of neurological function in a rat model of traumatic brain injury, Cell Transplant., 26, 1262, 10.1177/0963689717715168 Anderton, 2012, Co-regulation of survival of motor neuron and Bcl-XL expression: implications for neuroprotection in spinal muscular atrophy, Neuroscience, 220, 228, 10.1016/j.neuroscience.2012.06.042 Shishkina, 2010, Resistance to the development of stress-induced behavioral despair in the forced swim test associated with elevated hippocampal Bcl-XL expression, Behav. Brain Res., 213, 218, 10.1016/j.bbr.2010.05.003 Berezova, 2011, Behavior in the forced-swimming test and expression of BDNF and Bcl-XL genes in the rat brain, Zh Vyssh Nerv Deiat Im I P Pavlova, 61, 332 Shishkina, 2012, Stress-induced activation of the brainstem Bcl-XL gene expression in rats treated with fluoxetine: correlations with serotonin metabolism and depressive-like behavior, Neuropharmacology, 62, 177, 10.1016/j.neuropharm.2011.06.016 Dygalo, 2012, Increased expression of the anti-apoptotic protein Bcl-XL in the brain is associated with resilience to stress-induced depression-like behavior, Cell. Mol. Neurobiol., 32, 767, 10.1007/s10571-011-9794-y Dygalo, 2017, Effects of short-term exposure to lithium on antiapoptotic Bcl-XL protein expression in cortex and hippocampus of rats after acute stress, Biochemistry, 82, 345 Park, 2017, ΔN-Bcl-XL, a therapeutic target for neuroprotection, Neural Regen. Res., 12, 1791, 10.4103/1673-5374.219033 Park, 2017, Inhibition of Bcl-XL prevents pro-death actions of ΔN-Bcl-XL at the mitochondrial inner membrane during glutamate excitotoxicity, Cell Death Differ., 24, 1963, 10.1038/cdd.2017.123 Park, 2019, Vitamin E prevents ΔN-Bcl-XL-associate mitochondrial dysfunction in primary hippocampal neurons (P14-024-19), Curr Dev Nutr., 3 Stumpf, 2019, Lycopene protects cortical neurons via oxidative stress-mediated ΔN-Bcl-XL formation (FS05-08-19), Curr Dev Nutr., 3 Park, 2018, Nutritional regulators of Bcl-XL in the brain, Molecules, 23, E3019, 10.3390/molecules23113019 Kasahara, 2014, Mitochondria: from cell death executioners to regulators of cell differentiation, Trends Cell Biol., 24, 761, 10.1016/j.tcb.2014.08.005 Lan, 2019, The roles of mitochondria-associated membranes in mitochondrial quality control under endoplasmic reticulum stress, Life Sci., 231, 116587, 10.1016/j.lfs.2019.116587 Lee, 2018, The interface between ER and mitochondria: molecular compositions and functions, Mol. Cells, 41, 1000 Chen, 2011, Bcl-XL regulates mitochondrial energetics by stabilizing the inner membrane potential, J. Cell Biol., 195, 263, 10.1083/jcb.201108059 Tagami, 2000, A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity, Oncogene, 19, 5736, 10.1038/sj.onc.1203948 Williams, 2016, The non-apoptotic action of Bcl-XL: regulating Ca2+ signaling and bioenergetics at the ER-mitochondrion interface, J. Bioenerg. Biomembr., 48, 211, 10.1007/s10863-016-9664-x Monaco, 2012, Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-XL, Cell Death Differ., 19, 295, 10.1038/cdd.2011.97 Eno, 2012, Distinct roles of mitochondria- and ER-localized Bcl-XL in apoptosis resistance and Ca2+ homeostasis, Mol. Biol. Cell, 23, 2605, 10.1091/mbc.e12-02-0090 Huang, 2013, An interaction between Bcl-XL and the voltage-dependent anion channel (VDAC) promotes mitochondrial Ca2+ uptake, J. Biol. Chem., 288, 19870, 10.1074/jbc.M112.448290 Vervliet, 2017, Modulation of Ca2+ signaling by anti-apoptotic B-cell lymphoma 2 proteins at the endoplasmic reticulum-mitochondrial interface, Front. Oncol., 7, 75, 10.3389/fonc.2017.00075 Jonas, 2014, Contributions of Bcl-XL to acute and long term changes in bioenergetics during neuronal plasticity, Biochim. Biophys. Acta, 1842, 1168, 10.1016/j.bbadis.2013.11.007 Alavian, 2011, Bcl-XL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase, Nat. Cell Biol., 13, 1224, 10.1038/ncb2330 Luciani, 2013, Bcl-2 and Bcl-XL suppress glucose signaling in pancreatic β-cells, Diabetes, 62, 170, 10.2337/db11-1464 Thomas, 2009, Beta cell apoptosis in diabetes, Apoptosis, 14, 1389, 10.1007/s10495-009-0339-5 Soria, 2013, Dual trade of Bcl-2 and Bcl-XL in islet physiology, Diabetes, 62, 18, 10.2337/db12-1023 Hughes, 2006, Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases, Curr. Dir. Autoimmun., 9, 74 Grillot, 1995, Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice, J. Exp. Med., 182, 1973, 10.1084/jem.182.6.1973 Amanna, 2003, Enforced Bcl-XL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice, J. Immunol., 170, 4593, 10.4049/jimmunol.170.9.4593 Sharabi, 2010, Bcl-XL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide, J. Autoimmun., 34, 87, 10.1016/j.jaut.2009.06.002 Chen, 2010, Constitutive expression of Bcl-XL in the T lineage attenuates collagen-induced arthritis in Bcl-XL transgenic mice, Arthritis Rheum., 46, 514, 10.1002/art.10128 Haque, 2010, FoxP3 and Bcl-XL cooperatively promote regulatory T cell persistence and prevention of arthritis development, Arthritis Res. Ther., 12, R66, 10.1186/ar2983 Sharabi, 2010, Bcl-XL affects the development of functional CD4 tregs, Arthritis Res. Ther., 12, 405, 10.1186/ar3076 Qiao, 2016, Imbalanced expression of Bcl-XL and Bax in platelets treated with plasma from immune thrombocytopenia, Immunol. Res., 64, 604, 10.1007/s12026-015-8760-z Jones, 2017, Senescence is not inevitable, Biogerontology, 18, 965, 10.1007/s10522-017-9727-3 Zhu, 2015, The achilles’ heel of senescent cells: from transcriptome to senolytic drugs, Aging Cell, 14, 644, 10.1111/acel.12344 Rochette, 2008, Progressive apoptosis resistance prior to senescence and control by the anti-apoptotic protein Bcl-XL, Mech. Ageing Dev., 129, 207, 10.1016/j.mad.2007.12.007 Geiger, 2016, Depleting senescent cells to combat aging, Nat. Med., 22, 23, 10.1038/nm.4024 Yosef, 2016, Directed elimination of senescent cells by inhibition of Bcl-W and Bcl-XL, Nat. Commun., 7, 11190, 10.1038/ncomms11190 Pignolo, 2019, Exceptional human longevity, Mayo Clin. Proc., 94, 110, 10.1016/j.mayocp.2018.10.005 Borras, 2015, Centenarians overexpress Bcl-XL, which confers them a protection against apoptosis, oxidative stress and immunosenescence, Free Radic. Biol. Med., 86, S11, 10.1016/j.freeradbiomed.2015.07.051 Borras, 2016, Human exceptional longevity: transcriptome from centenarians is distinct from septuagenarians and reveals a role of Bcl-XL in successful aging, Aging, 8, 3185, 10.18632/aging.101078 Leverson, 2015, Exploiting selective Bcl-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy, Sci. Transl. Med., 7, 279ra40, 10.1126/scitranslmed.aaa4642